-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Epigenetics of Lymphomas

Program: Education Program
Session: Aggressive Lymphomas: What Novel Approaches Are Ready for Prime Time?
Hematology Disease Topics & Pathways:
Biological Processes, white blood cells, epigenetics, genomics
Monday, December 7, 2020, 11:25 AM-11:30 AM

Michael R Green, PhD

Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX

Disclosures: Green: KDAc Therapeutics: Current equity holder in private company.

Previous Presentation | Next Presentation >>